The attbf chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the attbf chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The attbf stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View attbf Detailed Price Forecast - CNN Money||View attbf Detailed Summary - Google Finance|
|View attbf Detailed Summary - Yahoo! Finance||View attbf Stock Research & Analysis - Zacks.com|
|View attbf Trends & Analysis - Trade-Ideas||View attbf Major Holders - Barrons|
|View attbf Call Transcripts - NASDAQ||View attbf Breaking News & Analysis - Seeking Alpha|
|View attbf Annual Report - CompanySpotlight.com||View attbf OTC Short Report - OTCShortReport.com|
|View attbf Fundamentals - TradeKing||View attbf SEC Filings - Bar Chart|
|View Historical Prices for attbf - The WSJ||View Performance/Total Return for attbf - Morningstar|
|View the Analyst Estimates for attbf - MarketWatch||View the Earnings History for attbf - CNBC|
|View the attbf Earnings - StockMarketWatch||View attbf Buy or Sell Recommendations - MacroAxis|
|View the attbf Bullish Patterns - American Bulls||View attbf Short Pain Metrics - ShortPainBot.com|
|View attbf Stock Mentions - StockTwits||View attbf Stock Mentions - PennyStockTweets|
|View attbf Stock Mentions - Twitter||View attbf Investment Forum News - Investor Hub|
|View attbf Stock Mentions - Yahoo! Message Board||View attbf Stock Mentions - Seeking Alpha|
|View Insider Transactions for attbf - SECform4.com||View Insider Transactions for attbf - Insider Cow|
|View attbf Major Holdings Summary - CNBC||View Insider Disclosure for attbf - OTC Markets|
|View Insider Transactions for attbf - Yahoo! Finance||View Institutional Holdings for attbf - NASDAQ|
|View attbf Stock Insight & Charts - FinViz.com||View attbf Investment Charts - StockCharts.com|
|View attbf Stock Overview & Charts - BarChart||View attbf User Generated Charts - Trading View|
Abattis Removed From BCSC Temporary Order
Posted on Thursday January 17, 2019
Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (ATTBF) is pleased to announce that the temporary order from the British Columbia Securities Commission (“BCSC”), issued on November 26, 2018 (the “Order”), has not been extended against Abattis. “Abattis is very happy with the BCSC’s decision to remove the Company from the Order such that Abattis can continue to focus its efforts on revenue generation and building shareholder value” stated Rob Abenante, President and CEO of Abattis.
Abattis Enters Into Definitive Share Exchange Agreement With NutriVida
Posted on Thursday January 10, 2019
Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (ATTBF) is pleased to announce that, further to its new release dated December 7, 2018, the Company has entered into a definitive share exchange agreement (the “Agreement”) with 1157016 B.C. Ltd., dba NutriVida, a private arm’s length company incorporated in the Province of British Columbia (“NutriVida”), pursuant to which the Company will acquire 100% of the issued and outstanding common shares of NutriVida (the “Acquisition”). In consideration for the Acquisition, and on closing thereof, the Company will issue an aggregate of 58,823,529 common shares (each, a “Share”) in the capital of Abattis, pro rata, to the NutriVida shareholders at a deemed price of $0.085 per Share and make a cash payment of $250,000 as provided in the Agreement.
Abattis Provides Marketing and Operational Updates
Posted on Friday December 21, 2018
Abattis Bioceuticals Corp (the “Company" or "Abattis") (CSE:ATT) (ATTBF) is pleased to announce the launch of its new website and provide an operational update. Abattis has recently unveiled its new marketing and branding materials, developed in conjunction with media company Canada One Communications Inc. (“Canada One”). Marketing materials include an updated website, corporate presentation and conference materials all highlighting Abattis’ new brand imagery (“new marketing materials”).
Vergence Naturals and Naturopathic Doctor and Nutraceutical Product Developer Brazos Minshew Launch Comfort
Posted on Tuesday December 18, 2018
VANCOUVER, British Columbia, Dec. 18, 2018 /PRNewswire/ -- Abattis Bioceuticals Corp (the "Company" or "Abattis") (ATT.CN) (ATTBF) is pleased to announce its first proprietary product, Comfort, which has been produced through wholly owned subsidiary Vergence Naturals ("Vergence"). Abattis has teamed up with respected naturopathic doctor and nutraceuticals product developer Dr. Brazos Minshew to launch Comfort, a breakthrough nutraceutical combining traditional herbal remedies to safely and effectively address occasional pain. Released on Cyber Monday and set for introduction into the US and Canada in December 2018, the Comfort product is 100% owned by Vergence, and will be marketed under the newly-formed health and wellness brand.